EGFR and vitiligo: According to the findings of the KEGG analysis, the mechanism of FHB for vitiligo therapy may involve pathways including “pathways in cancer”, “HIF-1 signaling pathway”, “FoxO signaling pathway”, “NF-kappa B signaling pathway”, “ErbB signaling pathway”, and “JAK-STAT signaling pathway” (Figure 3B).